7.1.5-header-iStock-932135810

Reimbursement Support

Increase access for your patients

Get in touch with a Rep

Bioventus provides best-in-class reimbursement support through BV360 Reimbursement Solution (HUB Services) for DUROLANE, GELSYN-3, and SUPARTZ FX.

BV360 features:

Benefit verifications in 24 hours, with insurance coverage information, out-of-pocket costs, and fulfillment options
Prior authorization and appeal support
Specialty pharmacy triage and tracking
Convenient MYBV360 provider portal with real-time status tracking, document upload, and chat feature
Live support and dedicated case managers
Reimbursement and coding information

Enroll your patients today:

Visit: The MyBV360 Provider Portal at MyBV360.com
Call: BV360 at 1-833-MyBV360 (1-833-692-8360)

Use the Reimbursement Guide to access product coding and reimbursement information.

Patient financial support:

Financial assistance program for underinsured patients
SUPARTZ FX direct-purchase program for patients
Copay support program

Enroll your patients today Visit MyBV360.com Provider Portal

DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

DUROLANE has not been tested in pregnant or lactating women, or children.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.